A Novel Marker of Inflammation: Azurocidin in Patients with ST Segment Elevation Myocardial Infarction

dc.contributor.author	Ipek, Emrah
dc.contributor.author	Yolcu, Mustafa
dc.contributor.author	Yildirim, Erkan
dc.contributor.author	Altinkaynak, Konca
dc.contributor.author	Sebin, Saime Ozbek
dc.contributor.author	Kalkan, Kamuran
dc.contributor.author	Gulcu, Oktay
dc.contributor.author	Ermis, Emrah
dc.contributor.author	Ozturk, Mustafa
dc.date.accessioned	2021-12-21T08:47:50Z
dc.date.available	2021-12-21T08:47:50Z
dc.date.issued	2018
dc.identifier.issn	1422-0067
dc.identifier.uri	https://doi.org/10.3390/ijms19123797
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2308
dc.description.abstract	(1) To investigate the role of azurocidin, an antimicrobial protein, in patients with ST segment elevation myocardial infarction (STEMI). (2) This single-center prospective observational study included patients with STEMI and healthy age- and sex-matched
dc.language.iso	English
dc.publisher	Mdpı
dc.rights	Green Published, gold, Green Submitted
dc.title	A Novel Marker of Inflammation: Azurocidin in Patients with ST Segment Elevation Myocardial Infarction
dc.type	Article
dc.relation.journal	Internatıonal Journal Of Molecular Scıences
dc.identifier.issue	12
dc.identifier.volume	19
dc.identifier.doi	10.3390/ijms19123797
dc.relation.issue	12
dc.relation.volume	19

Files in this item

Files	Size	Format	View
There are no files associated with this item.